The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy
Open Access
- 3 August 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 8 (8), 1736-1744
- https://doi.org/10.1111/j.1538-7836.2010.03953.x
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Postmenopausal Hormone Therapy and Risk of Idiopathic Venous ThromboembolismArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysisBMJ, 2008
- Calibrated automated thrombin generation in normal uncomplicated pregnancyThrombosis and Haemostasis, 2008
- Changes in Hemostatic Variables Induced by Estrogen Replacement Therapy: Comparison of Transdermal and Oral Administration in a Crossover-Designed StudyGynecologic and Obstetric Investigation, 2007
- Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal womenBMJ, 2007
- Effect of Oral and Transdermal Estrogen Replacement Therapy on Hemostatic Variables Associated With Venous ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Serum Estradiol-Binding Profiles in Postmenopausal Women Undergoing Three Common Estrogen Replacement TherapiesMenopause, 2000
- Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogensThe Lancet, 1996
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996